* 中国生物科技公司--康方生物9926.HK周一早盘一度升3%。
* 该公司此前公告称，奇佑康（古莫奇单抗，AK111）已获得中国国家药品监督管理局批准上市，用于治疗中度至重度斑块状银屑病。
* 康方生物今年迄今大跌17.5%，同期恒生指数.HSI下滑2.9%。
* 恒生生物科技指数.HSBIO盘中一度涨1.4%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 张喜良)
((kaiwen.xu@thomsonreuters.com))
* 中国生物科技公司--康方生物9926.HK周一早盘一度升3%。
* 该公司此前公告称，奇佑康（古莫奇单抗，AK111）已获得中国国家药品监督管理局批准上市，用于治疗中度至重度斑块状银屑病。
* 康方生物今年迄今大跌17.5%，同期恒生指数.HSI下滑2.9%。
* 恒生生物科技指数.HSBIO盘中一度涨1.4%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 张喜良)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.